PHRF1 and cancer: Consistent with that doxorubicin prevents ubiquitin-like with PHD and ring finger domains 1 (UHRF1) from binding to hemi-methylated DNA, our data indicate that doxorubicin-perturbed cancer-related genes, particularly those involved in cell-cycle regulation, represent a possible aspect of its mechanism of action.58